Supernus Pharmaceuticals, Inc. (0LB2.L)

USD 33.23

(3.01%)

Eps Summary of Supernus Pharmaceuticals, Inc.

  • Supernus Pharmaceuticals, Inc.'s latest annual eps in 2023 was 0.02 USD , down -97.87% from previous year.
  • Supernus Pharmaceuticals, Inc.'s latest quarterly eps in 2024 Q2 was 0.36 USD , up 15552.17% from previous quarter.
  • Supernus Pharmaceuticals, Inc. reported an annual eps of 1.13 USD in 2022, up 11.88% from previous year.
  • Supernus Pharmaceuticals, Inc. reported an annual eps of 1.01 USD in 2021, down -58.09% from previous year.
  • Supernus Pharmaceuticals, Inc. reported a quarterly eps of 0.36 USD for 2024 Q2, up 15552.17% from previous quarter.
  • Supernus Pharmaceuticals, Inc. reported a quarterly eps of 0.00 USD for 2024 Q1, down -89.3% from previous quarter.

Annual Eps Chart of Supernus Pharmaceuticals, Inc. (2023 - 2007)

Historical Annual Eps of Supernus Pharmaceuticals, Inc. (2023 - 2007)

Year Eps Eps Growth
2023 0.02 USD -97.87%
2022 1.13 USD 11.88%
2021 1.01 USD -58.09%
2020 2.41 USD 11.57%
2019 2.16 USD 1.41%
2018 2.13 USD 88.5%
2017 1.13 USD -38.59%
2016 1.84 USD 534.48%
2015 0.29 USD -38.3%
2014 0.47 USD 116.21%
2013 -2.90 USD -9.43%
2012 -2.65 USD -172.8%
2011 3.64 USD 230.94%
2010 -2.78 USD -1223.81%
2009 -0.21 USD 91.32%
2008 -2.42 USD -93.6%
2007 -1.25 USD 0.0%

Peer Eps Comparison of Supernus Pharmaceuticals, Inc.

Name Eps Eps Difference
uniQure N.V. -6.47 USD 100.372%
Abeona Therapeutics Inc. -2.53 USD 100.953%
Aclaris Therapeutics, Inc. -1.27 USD 101.898%
Agios Pharmaceuticals, Inc. -6.33 USD 100.381%
Atara Biotherapeutics, Inc. -65.18 USD 100.037%
Cara Therapeutics, Inc. -2.19 USD 101.1%
Imunon, Inc. -2.16 USD 101.116%
Dynavax Technologies Corporation -0.05 USD 148.589%
Editas Medicine, Inc. -2.02 USD 101.193%
FibroGen, Inc. -2.92 USD 100.825%
Iovance Biotherapeutics, Inc. -1.89 USD 101.275%
Kala Pharmaceuticals, Inc. -17.35 USD 100.139%
Neurocrine Biosciences, Inc. 2.56 USD 99.059%
Sarepta Therapeutics, Inc. -5.80 USD 100.416%
Verastem, Inc. -3.96 USD 100.609%
Zoetis Inc. 5.08 USD 99.526%
Vertex Pharmaceuticals Incorporated 14.05 USD 99.828%
Sangamo Therapeutics, Inc. -1.48 USD 101.628%
Homology Medicines, Inc. -7.41 USD 100.325%
Nektar Therapeutics -1.45 USD 101.662%
Viking Therapeutics, Inc. -0.91 USD 102.648%
Unity Biotechnology, Inc. -2.70 USD 100.893%
Perrigo Company plc -0.09 USD 125.666%
Esperion Therapeutics, Inc. -2.03 USD 101.187%
Walgreens Boots Alliance, Inc. -10.01 USD 100.241%
Illumina, Inc. -7.35 USD 100.328%
Thermo Fisher Scientific Inc. 15.53 USD 99.845%
IQVIA Holdings Inc. 7.39 USD 99.674%
Heron Therapeutics, Inc. -0.80 USD 103.013%
Waters Corporation 10.87 USD 99.778%
Biogen Inc. 8.02 USD 99.7%
Evolus, Inc. -1.08 USD 102.231%
Adicet Bio, Inc. -3.31 USD 100.728%
bluebird bio, Inc. -1.93 USD 101.249%
Geron Corporation -0.32 USD 107.531%
Alnylam Pharmaceuticals, Inc. -3.52 USD 100.685%
Amicus Therapeutics, Inc. -0.51 USD 104.725%
Myriad Genetics, Inc. -1.39 USD 101.734%
Intellia Therapeutics, Inc. -5.42 USD 100.445%
Mettler-Toledo International Inc. 36.10 USD 99.933%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 100.234%
BioMarin Pharmaceutical Inc. 0.89 USD 97.292%
Regeneron Pharmaceuticals, Inc. 37.05 USD 99.935%
Agilent Technologies, Inc. 4.22 USD 99.429%
OPKO Health, Inc. -0.25 USD 109.64%
Exelixis, Inc. 0.65 USD 96.292%
Corcept Therapeutics Incorporated 1.02 USD 97.637%
Anavex Life Sciences Corp. -0.60 USD 104.017%
Axsome Therapeutics, Inc. -5.27 USD 100.457%
Ionis Pharmaceuticals, Inc. -2.56 USD 100.941%
Halozyme Therapeutics, Inc. 2.13 USD 98.869%
Blueprint Medicines Corporation -8.37 USD 100.288%
Insmed Incorporated -5.34 USD 100.451%
TG Therapeutics, Inc. 0.09 USD 73.012%
Incyte Corporation 2.67 USD 99.097%
Emergent BioSolutions Inc. -14.85 USD 100.162%